Mineralys Therapeutics(MLYS) - 2024 Q2 - Earnings Call Presentation

| --- | --- | --- | |------------------------------------------------------------------|-------|-------| | | | | | | | | | Targeting Aldosterone in the Treatment of Cardiorenal Diseases | | | | J une 2024 | | | F o r w a r d-L o o k i n g S t a t e m e n t s a n d M a r k e t D a t a We caution you that this presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations ...